Regular physician follow-ups to track progress, adjust protocols, and ensure optimal therapeutic outcomes
Results were reportedly submitted to ClinicalTrials.gov on May 23, 2016, but the study itself is listed as canceled, which indicates the study sponsor or investigator recalled a submission of study results before quality control review took place
Avoids Serious Complications In patients with severe anaemia, intensive treatment with B12 may result in a sudden drop in potassium (hypokalaemia), which can cause muscle weakness or an irregular heartbeat
However, other methods (such as injection) can be considered more effective due to direct delivery
Dietz V, Wirz M, Curt A, Colombo G